Tailored Glycopolymers as Anticoagulant Heparin Mimetics

被引：86
|
作者：
Oh, Young In [1 ,2 ]
Sheng, Gloria J. [1 ,2 ]
Chang, Shuh-Kuen [3 ]
Hsieh-Wilson, Linda C. [1 ,2 ]
机构：
[1] CALTECH, Div Chem & Chem Engn, Pasadena, CA 91125 USA
[2] CALTECH, Howard Hughes Med Inst, Pasadena, CA 91125 USA
[3] Ohio State Univ, Dept Chem & Biochem, Columbus, OH 43210 USA
来源：
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION | 2013年 / 52卷 / 45期
基金：
美国国家卫生研究院;
关键词：
anticoagulant; biomimetic synthesis; drug discovery; glycopolymers; heparin; MOLECULAR-WEIGHT HEPARIN; CHONDROITIN SULFATE; HIGH-AFFINITY; ANTITHROMBIN; PENTASACCHARIDE; OLIGOSACCHARIDES; GENERATION; LIGANDS; BINDING; PROBES;
D O I：
10.1002/anie.201306968
中图分类号：
O6 [化学];
学科分类号：
0703 ;
摘要：
Not to clot: Heparin and its low-molecular-weight derivatives are clinical therapeutics used to treat and prevent blood clots. The synthesis of heparin-based glycopolymers that are potent and potentially safer mimetics of heparin is described. The mimetics exhibited activity against proteases (FXa and FIIa) in the coagulation cascade and prolonged blood clot times in human plasma with efficacies similar to those of clinical anticoagulants. ATIII=antithrombin-III. Copyright © 2013 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.
引用
收藏
页码：11796 / 11799
页数：4
相关论文
共 50 条
  • [41] CLINICAL EXPERIENCE ON AN ANTICOAGULANT OMEGA-HEPARIN (WHALE HEPARIN)
    HASHIMOTO, Y
    KAMIYA, K
    HORIO, K
    TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE, 1966, 88 (04): : 377 - 384
  • [42] EFFECT OF ISOPTINE ON THE ANTICOAGULANT ACTION OF HEPARIN SODIUM AND HEPARIN CALCIUM
    USHKALOVA, EA
    KREMNEVA, VF
    SHCHEGLOVA, NV
    FARMAKOLOGIYA I TOKSIKOLOGIYA, 1988, 51 (03): : 48 - 51
  • [43] Monitoring heparin in patients with a lupus anticoagulant: detection of heparin resistance
    Trenfield, S.
    Parmar, K.
    Hunt, B. J.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2008, 6 (11) : 1980 - 1982
  • [44] BIOSYNTHESIS OF HEPARIN PROTEOGLYCAN AND THE FUNCTIONAL DOMAINS FOR ANTICOAGULANT ACTIVITY OF HEPARIN
    YOSIZAWA, Z
    OTOTANI, N
    SEIKAGAKU, 1982, 54 (06): : 379 - 385
  • [45] ANTICOAGULANT EFFECTS OF HEPARIN IN NEONATAL PLASMA
    SCHMIDT, B
    OFOSU, FA
    MITCHELL, L
    BROOKER, LA
    ANDREW, M
    PEDIATRIC RESEARCH, 1989, 25 (04) : 405 - 408
  • [46] Heparin neutralizer Anticoagulant reversal agent
    Muralidharan-Chari, V.
    Mousa, S. A.
    DRUGS OF THE FUTURE, 2016, 41 (06) : 341 - 346
  • [47] Bioengineered human heparin with anticoagulant activity
    Lord, Megan S.
    Cheng, Bill
    Tang, Fengying
    Lyons, J. Guy
    Rnjak-Kovacina, Jelena
    Whitelock, John M.
    METABOLIC ENGINEERING, 2016, 38 : 105 - 114
  • [48] DISAPPEARANCE RATE OF ANTICOAGULANT EFFECT OF HEPARIN
    DESWART, CAM
    NIJMEIJER, A
    AKKERMAN, JWN
    SIXMA, JJ
    THROMBOSIS ET DIATHESIS HAEMORRHAGICA, 1975, 34 (03): : 886 - 886
  • [49] ADVANCES IN UNDERSTANDING OF ANTICOAGULANT FUNCTION OF HEPARIN
    ROSENBERG, JS
    ROSENBERG, RD
    CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 1975, 18 (01): : 66 - 78
  • [50] Heparin as an Anticoagulant for the Dielectric Measurement of Blood
    Dunne, Eoghan
    O'Halloran, Martin
    Porter, Emily
    Bonello, Julian
    Farrugia, Lourdes
    Sammut, Charles V.
    Schembri-Wismayer, Pierre
    IEEE TRANSACTIONS ON DIELECTRICS AND ELECTRICAL INSULATION, 2019, 26 (01) : 229 - 234
12345